Abhinav Jain's most recent trade in Aytu BioPharma Inc was a trade of 1,500 Common Shares done . Disclosure was reported to the exchange on Nov. 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma Inc | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,500 | 9,500 (0%) | 0% | 0 | Common Shares | |
| Talphera Inc. | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 13,044 | 13,044 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc. | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 2,174 | 3,045 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Jain Abhinav | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 5,228 | 5,228 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 871 | 871 (0%) | 0% | 0 | Common Stock | |
| Aytu BioPharma Inc | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 6,500 | 8,000 (0%) | 0% | 0 | Common Shares | |
| Aytu BioPharma Inc | Abhinav Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 1,500 | 1,500 (0%) | 0% | 0 | Common Shares |